The Global Assistive Reproductive Technology Market is predicted to grow to USD 43.2 billion by 2030.

Category: Healthcare

RELEASE DATE Nov 2022
REPORT ID SI1319

A PHP Error was encountered

Severity: Notice

Message: Undefined variable: table

Filename: press/detail.php

Line Number: 118

Backtrace:

File: /home/admin/web/sphericalinsights.com/public_html/application/views/press/detail.php
Line: 118
Function: _error_handler

File: /home/admin/web/sphericalinsights.com/public_html/application/views/layouts/master_header_footer.php
Line: 720
Function: view

File: /home/admin/web/sphericalinsights.com/public_html/application/controllers/Press.php
Line: 89
Function: view

File: /home/admin/web/sphericalinsights.com/public_html/index.php
Line: 295
Function: require_once

Global Assistive Reproductive Technology Market worth $43.2 billion by 2030

According to a research report published by Spherical Insights & Consulting, the Global Assistive Reproductive Technology Market Size to grow from USD 23.5 billion in 2021 to USD 43.2 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 7% during the forecast period. 

Assistive Reproductive

Get more details on this report -

Request Free Sample PDF

The assistive reproductive technology market has grown because the number of cases of infertility is rising due to rising stress, obesity, pollution, and changing lifestyles

 

Browse 47 market data Tables and 57 Figures spread through 185 Pages and in-depth TOC on Global Assistive Reproductive Technology Market Size, Share, and COVID-19 Impact Analysis, By Technology (In Vitro-fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Replacement (FER), and others), End-Users (Hospital, and Fertility Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.

 

View a detailed Table of Content here– https://www.sphericalinsights.com/reports/assistive-reproductive-technology-market

 

Credit portfolios have been negatively impacted by the COVID-19 outbreak. The solvency of customers and businesses has been hampered by the enormous growth in unemployment and interruption of economic activity. Injecting money into the market by decreasing interest rates and implementing asset purchase programmes, central banks have adopted a proactive strategy.

 

With persistent geopolitical tensions, global trade battles, and sporadic hurricanes and earthquakes, managing and monitoring credit, market, liquidity, and operational risk across financial markets was challenging enough. Chief risk officers and their teams have had to reevaluate outdated methods and assumptions used to manage and monitor risk as a result of the present pandemic crisis. 

 

The global repercussions of COVID-19 have demonstrated the significance of interconnection in international cooperation. As a result, many governments have been hurrying to find, assess, and buy trustworthy AI-powered solutions.

 

The In Vitro-fertilization (IVF) segment to account for the largest market size during the forecast period

Based on the technology, the global assistive reproductive technology market is categorized into In Vitro-fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Replacement (FER), and others.  The   In Vitro-fertilization (IVF) segment to account for the largest market size during the forecast period.

 

The development of IVF technology, rising public awareness and government measures to control surrogacy, and expanding insurance coverage of IVF are some other significant aspects that are anticipated to have a significant impact on the development of the investigated market. As an illustration, the Indian state of Odisha established the state-assisted reproductive technologies and surrogacy board in June 2022 with the aim of regulating in vitro fertilization (IVF) clinics and outlawing commercial surrogacy.

 

The Fertility clinics segment to hold a higher CAGR during the forecast period.

Based on the end-user, the assistive reproductive technology market is categorized into Hospitals and Fertility Clinics. The Fertility clinics segment to hold a higher CAGR during the forecast period. The sector is anticipated to continue growing at the fastest rate, maintaining its position as the market leader during the forecast period.

The high percentage and quick expansion can be ascribed to an increase in infertility cases and the demand for a specialized setting to carry out ART.

 

Europe Market

Get more details on this report -

Request Free Sample PDF

 

 Europe to hold a higher CAGR during the forecast period.

The Global Assistive Reproductive Technology Market has been segmented into five major regions:  North America, Europe, Asia-Pacific, South America, The Middle East and Africa.  Europe is estimated to account for the highest market share in 2022. During the forecast period, the sector is expected to keep expanding at the highest rate and hold the top spot in the market.

 

An increase in infertility cases and the need for a specialized setting to perform ART can be blamed for the high percentage and rapid growth. For instance, the West Asian company Gulf Capitals ART Fertility Facilities declared plans to invest USD 31.3 million in the development of 18 clinics in significant Indian cities by 2023.

 

Additional factors that are anticipated to support segment expansion throughout the forecast period are cost-effectiveness, specialization, domain knowledge, and individualized treatment.

Major vendors in the Global Assistive Reproductive Technology Market include Cosmos Biomedical Ltd., Microm U.K. Ltd., CooperSurgical, Inc., FUJIFILM Irvine Scientific, Cryolab Ltd., Vitrolife AB, European Sperm Bank, Bloom IVF Centre, Merck KGaA, and Ferring B.V.

 

Contact Us: https://www.sphericalinsights.com/contact-us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies